These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Biologics: a new approach needed? Foster KA Drug Discov Today; 2010 Feb; 15(3-4):81-3. PubMed ID: 19778630 [No Abstract] [Full Text] [Related]
7. The use of biologics and other immunosuppressants in the treatment of common inflammatory diseases in neuro-ophthalmology. Miller KB; Foroozan R Int Ophthalmol Clin; 2007; 47(4):151-60, x. PubMed ID: 18049287 [No Abstract] [Full Text] [Related]
8. Interaction of mechanics and biology in knee joint restoration and regeneration. From cells to limbs--multi-scale approaches for clinical applications. Berlin, 28-30 June 2006. Duda GN; Haas NP; Heller MO; Taylor WR J Biomech; 2007; 40 Suppl 1():S1-3. PubMed ID: 17543970 [No Abstract] [Full Text] [Related]
10. Long-term safety of biologics in dermatology. Lima XT; Seidler EM; Lima HC; Kimball AB Dermatol Ther; 2009; 22(1):2-21. PubMed ID: 19222513 [TBL] [Abstract][Full Text] [Related]
11. Using Medicare administrative data to conduct postmarketing surveillance of follow-on biologics: issues and opportunities. DiMartino LD; Curtis LH; Williams RL; Abernethy DR; Schulman KA Food Drug Law J; 2008; 63(4):891-900. PubMed ID: 19601387 [No Abstract] [Full Text] [Related]
12. New biologics for psoriasis and psoriatic arthritis. Rozenblit M; Lebwohl M Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517 [TBL] [Abstract][Full Text] [Related]
13. Re: "Patellar tendon length following knee arthroplasty with and without preservation of the infrapatellar fat pad "(Lemon et al.). Grelsamer RP J Arthroplasty; 2009 Apr; 24(3):487. PubMed ID: 19304063 [No Abstract] [Full Text] [Related]
20. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know? Alwawi EA; Krulig E; Gordon KB Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]